Home  > 
  Cellectis studies safety in new CAR architecture controlling CAR T-cell functions,   January 24, 2017
  Sanifit enrolls first patient in phase IIb CaLIPSO study to treat cardiovascular calcification in ESRD patients on haemodialsis,   January 24, 2017
  Otonomy enrolls first patient in phase 2 study of OTO-104 for prevention of hearing loss,   January 21, 2017
  Dermata starts dosing patients in phase 2 acne rosacea clinical study,   January 20, 2017
  Sobi enrolls first patient in A-SURE study evaluating effectiveness of Elocta,   January 20, 2017
  Daiichi Sankyo begins phase 1/2 study of U3-1402 in HER3-positive metastatic/unresectable breast cancer patients,   January 20, 2017
  Caris Life, Lustgarten Foundation collaborate to support immunotherapy clinical trial for pancreatic cancer,   January 20, 2017
  Theravance to present new data from TOUR study of Vibativ at SCCM critical care congress,   January 19, 2017
  Lifestyle Delivery Systems plans to conduct clinical trials of CannaStrips in Canada,   January 18, 2017
  Chi-Med initiates phase II study of sulfatinib in second-line BTC patients in China,   January 18, 2017
  Allergan, Gedeon Richter report positive results from phase III trial of ulipristal acetate to treat uterine fibroids,   January 17, 2017
  Chi-Med begins phase II combo study of fruquintinib with Iressa to treat NSCLC,   January 17, 2017
  Tocagen begins enrolling patients in Toca 5 phase 2/3 trial in South Korea to treat recurrent brain cancer,   January 16, 2017
  Pluristem completes patient enrollment in phase II trial of PLX-PAD cells to treat intermittent claudication,   January 16, 2017
  Visterra begins enrollment in phase 2a trial of VIS410 to treat hospitalized patients with influenza A,   January 13, 2017
  Sobi announces first patient randomised in phase II study of anakinra to treat acute gout,   January 13, 2017
  MorphoSys partner Norvatis to begin phase 2 trial of HuCAL antibody bimagrumab in obese patients with type 2 diabetes,   January 13, 2017
  Vtesse begins patient dosing in phase 2b/3 trial of VTS-270 in NPC disease in Australia,   January 12, 2017
  Enanta reports positive results from phase 3 CERTAIN-1 study of genotype 1 chronic HCV infected Japanese patients,   January 11, 2017
  OPKO Health begins Claros 1 trial for Total PSA,   January 11, 2017

Pharma Project Management 2017
Copyright © 2016 Saffron Media Pvt. Ltd |